Assessment of tissue perfusion by contrast-enhanced ultrasound
E Quaia - European radiology, 2011 - Springer
Contrast-enhanced ultrasound (CEUS) with microbubble contrast agents is a new imaging
technique for quantifying tissue perfusion. CEUS presents several advantages over other …
technique for quantifying tissue perfusion. CEUS presents several advantages over other …
Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation
SL Barnes, JG Whisenant, ME Loveless, TE Yankeelov - Pharmaceutics, 2012 - mdpi.com
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) consists of the
continuous acquisition of images before, during, and after the injection of a contrast agent …
continuous acquisition of images before, during, and after the injection of a contrast agent …
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assess tumor
perfusion, microvascular vessel wall permeability and extravascular–extracellular volume …
perfusion, microvascular vessel wall permeability and extravascular–extracellular volume …
[HTML][HTML] Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
U Fasol, A Frost, M Büchert, J Arends, U Fiedler… - Annals of oncology, 2012 - Elsevier
ABSTRACT Background EndoTAG-1 (ET), a novel formulation of cationic liposomes carrying
embedded paclitaxel (Taxol), shows antitumoral activity, targeting tumor endothelial cells in …
embedded paclitaxel (Taxol), shows antitumoral activity, targeting tumor endothelial cells in …
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
KKY Cham, JHE Baker, KS Takhar, JA Flexman… - British journal of …, 2010 - nature.com
Background: The current standard of care for pancreatic cancer is weekly gemcitabine
administered for 3 of 4 weeks with a 1-week break between treatment cycles. Maximum …
administered for 3 of 4 weeks with a 1-week break between treatment cycles. Maximum …
Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization
S Pitre-Champagnat, I Leguerney, J Bosq… - Investigative …, 2015 - journals.lww.com
Objectives The purposes of this study were to assess the reliability of parametric maps from
dynamic contrast-enhanced ultrasound (DCE-US) to reflect the heterogeneous distribution …
dynamic contrast-enhanced ultrasound (DCE-US) to reflect the heterogeneous distribution …
[PDF][PDF] Imaging innovations for cancer therapy response monitoring
Innovative imaging approaches for monitoring various types of cancer treatment response
are discussed in this paper. Radionuclide imaging has demonstrated favorable capabilities …
are discussed in this paper. Radionuclide imaging has demonstrated favorable capabilities …
Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography
S Lavisse, P Lejeune, V Rouffiac, N Elie… - Investigative …, 2008 - journals.lww.com
Objectives: To evaluate the early tumor vasculature disrupting effects of the AVE8062
molecule and the feasibility of dynamic contrast-enhanced ultrasonography (DCE-US) in the …
molecule and the feasibility of dynamic contrast-enhanced ultrasonography (DCE-US) in the …
The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT,-MRI and-US in patients with metastatic renal cell …
Objectives To identify dynamic contrast-enhanced (DCE) imaging parameters from MRI, CT
and US that are prognostic and predictive in patients with metastatic renal cell cancer …
and US that are prognostic and predictive in patients with metastatic renal cell cancer …
[HTML][HTML] Study on the characteristics of contrast-enhanced ultrasound and its utility in assessing the microvessel density in ovarian tumors or tumor-like lesions
J Wang, F Lv, X Fei, Q Cui, L Wang, X Gao… - … journal of biological …, 2011 - ncbi.nlm.nih.gov
Angiogenesis is a critical factor in tumor growth and metastasis, and microvessel density
(MVD) was an important parameter for assessing vessels in tumors. However, radiologic …
(MVD) was an important parameter for assessing vessels in tumors. However, radiologic …